Clinical Trial Update: Inhaled Sodium Nitrite as an Antimicrobial for Cystic Fibrosis [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 clinical trial evaluating inhaled sodium nitrite as an antimicrobial for cystic fibrosis was terminated; results were posted in 2024.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cystic Fibrosis

Drugs mentioned

• Inhaled Sodium Nitrite (sodium nitrite)

Snippet

Sponsor: Schmidhofer, Mark, MD | Conditions: Cystic Fibrosis | Phase 1, Phase 2 | Status: TERMINATED | Results posted: 2024-06-24